117 related articles for article (PubMed ID: 30995898)
21. In situ correlation of synthesis and storage of parathormone in parathyroid gland disease.
Kendall CH; Potter L; Brown R; Jasani B; Pringle JH; Lauder I
J Pathol; 1993 Jan; 169(1):61-6. PubMed ID: 8433215
[TBL] [Abstract][Full Text] [Related]
22. Hyperplasia in glands with hormone excess.
Marx SJ
Endocr Relat Cancer; 2016 Jan; 23(1):R1-14. PubMed ID: 26407873
[TBL] [Abstract][Full Text] [Related]
23. Exclusive underexpression of vitamin D receptor exon 1f transcripts in tumors of primary hyperparathyroidism.
Correa P; Akerstrom G; Westin G
Eur J Endocrinol; 2002 Nov; 147(5):671-5. PubMed ID: 12444900
[TBL] [Abstract][Full Text] [Related]
24. Differential RNA expression profile by cDNA microarray in sporadic primary hyperparathyroidism (pHPT): primary parathyroid hyperplasia versus adenoma.
Velázquez-Fernández D; Laurell C; Saqui-Salces M; Pantoja JP; Candanedo-Gonzalez F; Reza-Albarrán A; Gamboa-Dominguez A; Herrera MF
World J Surg; 2006 May; 30(5):705-13. PubMed ID: 16680586
[TBL] [Abstract][Full Text] [Related]
25. Underexpression of Gcm2, a master regulatory gene of parathyroid gland development, in adenomas of primary hyperparathyroidism.
Correa P; Akerström G; Westin G
Clin Endocrinol (Oxf); 2002 Oct; 57(4):501-5. PubMed ID: 12354132
[TBL] [Abstract][Full Text] [Related]
26. Endothelin receptors in human parathyroid gland.
Eguchi S; Hirata Y; Imai T; Kanno K; Akiba T; Sakamoto A; Yanagisawa M; Masaki T; Marumo F
Biochem Biophys Res Commun; 1992 May; 184(3):1448-55. PubMed ID: 1375462
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometric DNA analysis of benign hyperfunctioning parathyroid glands: significant difference in the S phase fraction and proliferative index between adenomas and hyperplasias.
Berczi C; Bocsi J; Balázs G; Lukács G
Pathology; 2002 Oct; 34(5):442-5. PubMed ID: 12408343
[TBL] [Abstract][Full Text] [Related]
28. Apoptosis and P53, Bcl-2 and Bax gene expression in parathyroid glands of patients with hyperparathyroidism.
Szende B; Farid P; Végso G; Perner F; Kopper L
Pathol Oncol Res; 2004; 10(2):98-103. PubMed ID: 15188026
[TBL] [Abstract][Full Text] [Related]
29. A comparative study of the int-2 gene product in primary and secondary parathyroid lesions.
Tseleni-Balafouta S; Thomopoulou G; Lazaris ACh; Koutselini H; Davaris PS
Eur J Endocrinol; 2002 Jan; 146(1):57-60. PubMed ID: 11751068
[TBL] [Abstract][Full Text] [Related]
30. Hyalinizing parathyroid adenoma and hyperplasia: report of 3 cases of an unusual histologic variant.
Elgoweini M; Chetty R
Ann Diagn Pathol; 2011 Oct; 15(5):329-32. PubMed ID: 21498097
[TBL] [Abstract][Full Text] [Related]
31. The expression of parathyroid hormone messenger RNA in normal and abnormal parathyroid tissue.
Kendall CH; Roberts PA; Pringle JH; Lauder I
J Pathol; 1991 Oct; 165(2):111-8. PubMed ID: 1744796
[TBL] [Abstract][Full Text] [Related]
32. Cox-2 expression in the oxyphilic cells of the normal, hyperplastic, and adenomatous parathyroid gland.
Bell CD; Vidal S; Kovacs K; Anderson J; Rotondo F
Endocr Pathol; 2004; 15(1):29-38. PubMed ID: 15067174
[TBL] [Abstract][Full Text] [Related]
33. Calmodulin and calmodulin-dependent protein kinase II inhibit hormone secretion in human parathyroid adenoma.
Lu M; Berglund E; Larsson C; Höög A; Farnebo LO; Bränström R
J Endocrinol; 2011 Jan; 208(1):31-9. PubMed ID: 20974637
[TBL] [Abstract][Full Text] [Related]
34. Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism.
Buchwald PC; Akerström G; Westin G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):389-93. PubMed ID: 15009006
[TBL] [Abstract][Full Text] [Related]
35. Synchronous water-clear cell double parathyroid adenomas a hitherto uncharacterized entity?
Kuhel WI; Gonzales D; Hoda SA; Pan L; Chiu A; Giri D; DeLellis RA
Arch Pathol Lab Med; 2001 Feb; 125(2):256-9. PubMed ID: 11175646
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of Insulin-like growth factor-1, Transforming growth factor-beta1, and Vascular endothelial growth factor in parathyroid adenoma and hyperplasia.
Sayar H; Sahin M; Dogan PO; Karabulut S; Seringec N; Oguz A
Indian J Pathol Microbiol; 2014; 57(4):549-52. PubMed ID: 25308005
[TBL] [Abstract][Full Text] [Related]
37. Expression of nitric oxide synthases in parathyroid gland adenoma and parathyroid gland hyperplasia.
Kucera T; Veselý D; Pácová H; Martínek J; Astl J
Neuro Endocrinol Lett; 2005 Aug; 26(4):373-6. PubMed ID: 16136006
[TBL] [Abstract][Full Text] [Related]
38. GCMB gene, a master regulator of parathyroid gland development, expression, and regulation in hyperparathyroidism.
Kebebew E; Peng M; Wong MG; Ginzinger D; Duh QY; Clark OH
Surgery; 2004 Dec; 136(6):1261-6. PubMed ID: 15657585
[TBL] [Abstract][Full Text] [Related]
39. [Changes in gene expression in the course of proliferative processes in the parathyroid gland].
Szende B; Arvai K; Peták I; Nagy K; Végsô G; Perner F
Magy Onkol; 2006; 50(2):137-40. PubMed ID: 16888677
[TBL] [Abstract][Full Text] [Related]
40. Reduced Calcium Sensing Receptor (CaSR) Expression Is Epigenetically Deregulated in Parathyroid Adenomas.
Singh P; Bhadada SK; Dahiya D; Arya AK; Saikia UN; Sachdeva N; Kaur J; Brandi ML; Rao SD
J Clin Endocrinol Metab; 2020 Sep; 105(9):3015-24. PubMed ID: 32609827
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
